The DOI matches its Crossref record; 244 of the 244 references it cites were found in a registry or an index.
Nucleic acid aptamers in cancer research, diagnosis and therapy
Abstract
A comprehensive, up-to-date aptamer review with a specific focus on the cancer field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Items 201–244 of 244
Thioaptamer Conjugated Liposomes for Tumor Vasculature Targeting
Mann, A. P., Bhavane, R. C., Somasunderam, A., Montalvo-Ortiz, B. L., Ghaghada, K. B., Volk, D. E., Nieves-Alicea, R., Suh, K. S., Mauro Ferrari, B., Annapragada, A., et al. (2010) · Oncotarget · doi:10.18632/oncotarget.261 · Cited by 91
Specific capture and temperature-mediated release of cells in an aptamer-based microfluidic device
Zhu, J., Nguyen, T., Pei, R., Stojanović, M. N., & Lin, Q. (2012) · Lab on a Chip · doi:10.1039/c2lc40411g · Cited by 90
In Vitro Selection of RNA Aptamer and Specific Targeting of ErbB2 in Breast Cancer Cells
Kim, M. Y., & Jeong, S. (2011) · Nucleic Acid Therapeutics · doi:10.1089/nat.2011.0283 · Cited by 89
Velocity Effect on Aptamer-Based Circulating Tumor Cell Isolation in Microfluidic Devices
Wan, Y., Tan, J., Asghar, W., Kim, Y. T., Liu, Y., & Iqbal, S. M. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp205511m · Cited by 88
Self-citationOverlapping RNA and DNA binding domains of the wt1 tumor suppressor gene product
Bardeesy, N. M., & Pelletier, J. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.7.1784 · Cited by 85
RNA Aptamer Evolution: Two Decades of SELEction
Aquino‐Jarquín, G., & Toscano-Garibay, J. D. (2011) · International Journal of Molecular Sciences · doi:10.3390/ijms12129155 · Cited by 85
Biosensors Based on Aptamers and Enzymes
Gu, M. B., & Kim, H. (2014) · Advances in biochemical engineering, biotechnology · doi:10.1007/978-3-642-54143-8 · Cited by 83
Cytoplasmic RNA modulators of an inside-out signal-transduction cascade
Blind, M., Kolanus, W., & Famulok, M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3606 · Cited by 83
Effects of nanopillar array diameter and spacing on cancer cell capture and cell behaviors
Wang, S., Wan, Y., & Liu, Y. (2014) · Nanoscale · doi:10.1039/c4nr02854f · Cited by 83
Self-citationOligonucleotide Inhibitors of P-Selectin-Dependent Neutrophil-Platelet Adhesion
JENISON, R. D., Jennings, S. D., WALKER, D. W., Bargatze, R. F., & Parma, D. H. (1998) · Antisense and Nucleic Acid Drug Development · doi:10.1089/oli.1.1998.8.265 · Cited by 79
Qu, L., Xu, J., Tan, X., Liu, Z., Xu, L., & Peng, R. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am5006783 · Cited by 79
Lee, H. K., Choi, Y. S., Park, Y. A., & Jeong-Yu, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-2526 · Cited by 78
Cell Specific Aptamer–Photosensitizer Conjugates as a Molecular Tool in Photodynamic Therapy
Mallikaratchy, P. R., Tang, Z., & Tan, W. (2007) · ChemMedChem · doi:10.1002/cmdc.200700260 · Cited by 76
Proteomics and diagnostics: Let's Get Specific, again
Zichi, D., Eaton, B. E., Singer, B. S., & Gold, L. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.01.016 · Cited by 75
Mi, J., Zhang, X., Giangrande, P. H., McNamara, J. O., Nimjee, S. M., Sarraf‐Yazdi, S., Sullenger, B. A., & Clary, B. M. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.10.043 · Cited by 74
Genomic SELEX: A discovery tool for genomic aptamers
Zimmermann, B., Bilusic, I., Lorenz, C., & Schroeder, R. (2010) · Methods · doi:10.1016/j.ymeth.2010.06.004 · Cited by 74
Ray, P., Rialon-Guevara, K. L., Veras, E. F. T., Sullenger, B. A., & White, R. R. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62385 · Cited by 72
A gold nanocage–CNT hybrid for targeted imaging and photothermal destruction of cancer cells
Khan, S. A., Kanchanapally, R., Fan, Z., Beqa, L., Singh, A. K., Senapati, D., & Ray, P. C. (2012) · Chemical Communications · doi:10.1039/c2cc32313c · Cited by 72
Optimizing Aptamer Activity for Gene Therapy Applications Using Expression Cassette SELEX
Martell, R. E., Nevins, J. R., & Sullenger, B. A. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0624 · Cited by 72
Jeong-Yu, S., Eom, T.-Y., Kim, S.-J., Lee, S., & Yu, J. (2001) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2001.4327 · Cited by 70
Lin, Y.-L. (1996) · Nucleic Acids Research · doi:10.1093/nar/24.17.3407 · Cited by 67
Self‐Assembled Aptamer‐Based Drug Carriers for Bispecific Cytotoxicity to Cancer Cells
Zhu, G., Meng, L. H., Ye, M., Yang, L. S., Sefah, K., O’Donoghue, M. B., Chen, Y., Xiong, X., Huang, J. L., Song, E., et al. (2012) · Chemistry - An Asian Journal · doi:10.1002/asia.201101060 · Cited by 66
Lebars, I., Legrand, P., Aimé, A., Pinaud, N., Fribourg, S., & Primo, C. D. (2008) · Nucleic Acids Research · doi:10.1093/nar/gkn831 · Cited by 65
Methods To Identify Aptamers against Cell Surface Biomarkers
Cibiel, A., Dupont, D. M., & Ducongè, F. (2011) · Pharmaceuticals · doi:10.3390/ph4091216 · Cited by 65
Hood, L., Omenn, G. S., Moritz, R. L., Aebersold, R. H., Yamamoto, K. R., Amos, M. D., Hunter‐Cevera, J., Locascio, L. E., & Participants, W. (2012) · PROTEOMICS · doi:10.1002/pmic.201270086 · Cited by 64
Discriminatory aptamer reveals serum response element transcription regulated by cytohesin-2
Theis, M., Knorre, A., Kellersch, B., Moelleken, J., Wieland, F., Kolanus, W., & Famulok, M. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402901101 · Cited by 62
Aptamers as Reagents for High-Throughput Screening
Green, L. S., Bell, C. J., & Janjić, N. (2001) · BioTechniques · doi:10.2144/01305dd02 · Cited by 62
RNA Molecules That Bind to and Inhibit the Active Site of a Tyrosine Phosphatase
Bell, S. D., Denu, J. M., Dixon, J. E., & Ellington, A. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14309 · Cited by 59
Controlled viable release of selectively captured label-free cells in microchannels
Gurkan, U. A., Anand, T., Taş, H., Elkan, D., Akay, A., Keleş, H. O., & Demirci, U. (2011) · Lab on a Chip · doi:10.1039/c1lc20487d · Cited by 57
Life's Simple Measures: Unlocking the Proteome
Brody, E., Gold, L., Mehan, M., Ostroff, R., Rohloff, J., Walker, J., & Zichi, D. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.06.021 · Cited by 54
Lee, H. K., Kwak, H. Y., Hur, J., Kim, I. A., Yang, J., Park, M. W., Yu, J., & Jeong-Yu, S. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1128 · Cited by 54
PEI protected aptamer molecular probes for contrast-enhanced in vivo cancer imaging
Gong, P., Shi, B., Zheng, M., Bi, W., Zhang, P., Hu, D., Gao, D., Sheng, Z., Zheng, C., Ma, Y., et al. (2012) · Biomaterials · doi:10.1016/j.biomaterials.2012.07.011 · Cited by 52
Antimetastatic Potential of PAI-1–Specific RNA Aptamers
Blake, C. M., Sullenger, B. A., Lawrence, D. A., & Fortenberry, Y. M. (2009) · Oligonucleotides · doi:10.1089/oli.2008.0177 · Cited by 52
A Semianalytic Model of Leukocyte Rolling
Krasik, E. F., & Hammer, D. A. (2004) · Biophysical Journal · doi:10.1529/biophysj.104.039693 · Cited by 51
Cell detachment: Post-isolation challenges
Zheng, Q., Iqbal, S. M., & Wan, Y. (2013) · Biotechnology Advances · doi:10.1016/j.biotechadv.2013.08.013 · Cited by 49
Self-citationMufhandu, H. T., Gray, E. S., Madiga, M., Tumba, N., Alexandre, K. B., Khoza, T., Wibmer, C. K., Moore, P. L., Morris, L., & Khati, M. (2012) · Journal of Virology · doi:10.1128/jvi.06893-11 · Cited by 47
Ara, M. N., Hyodo, M., Ohga, N., Hida, K., & Harashima, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0050174 · Cited by 44
Generation of RNA Aptamers to the G-Protein-Coupled Receptor for Neurotensin, NTS-1
Daniels, D. A., Sohal, A. K., Rees, S., & Grisshammer, R. (2002) · Analytical Biochemistry · doi:10.1006/abio.2002.5663 · Cited by 43
Ko, B.-H., Paik, J.-Y., Jung, K., & Lee, K.-H. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.074708 · Cited by 41
Nanoparticle Coatings for Enhanced Capture of Flowing Cells in Microtubes
Han, W. M., Allio, B. A., Foster, D. G., et al. (2009) · ACS Nano · doi:10.1021/nn900442c · Cited by 36
Synthesis and biological activities of a phosphorodithioate analog of 2′, 5′-oligoadenylate
Beigelman, L. N., Matulić‐Adamić, J., Haeberli, P., Usman, N., Dong, B., Silverman, R. H., Khamnei, S., & Torrence, P. F. (1995) · Nucleic Acids Research · doi:10.1093/nar/23.19.3989 · Cited by 32
RNA aptamers that specifically bind to the Ras‐binding domain of Raf‐1
Kimoto, M., Sakamoto, K., Shirouzu, M., Hirao, I., & Yokoyama, S. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01572-5 · Cited by 21
White, R. R., Roy, J. A., Viles, K. D., Sullenger, B. A., & Kontos, C. D. (2008) · Angiogenesis · doi:10.1007/s10456-008-9122-4 · Cited by 20
In-vitro and in-vivo antagonistic action of an anti-amylin Spiegelmer
Bilik, K. U., Ergüven, E., Klußmann, S., Jarosch, F., Wielinga, P. Y., Lutz, T. A., & Riediger, T. (2007) · Neuroreport · doi:10.1097/wnr.0b013e3282f1ab04 · Cited by 12
Cited by
Hildebrandt, N., Spillmann, C. M., Algar, W. R., Pons, T., Stewart, M. H., Oh, E., Susumu, K., Díaz, S. A., Delehanty, J. B., & Medintz, I. L. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.6b00030 · Cited by 730
Aptamer-Based Detection of Circulating Targets for Precision Medicine
Wu, L., Wang, Y., Xu, X., Liu, Y., Lin, B., Zhang, M., Zhang, J., Wan, S., Yang, C., & Tan, W. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.0c01140 · Cited by 705
Aptamer-integrated DNA nanostructures for biosensing, bioimaging and cancer therapy
Meng, H.-M., Liu, H., Kuai, H., Peng, R., Mo, L., & Zhang, X.-B. (2016) · Chemical Society Reviews · doi:10.1039/c5cs00645g · Cited by 608
You, H., Mu, Z., Zhao, M., Zhou, J., Chen, Y., & Bai, L. (2019) · Microchimica Acta · doi:10.1007/s00604-018-3127-5 · Cited by 592
Nanotechnology in cancer diagnosis: progress, challenges and opportunities
Zhang, Y., Li, M., Gao, X., Chen, Y., & Liu, T. (2019) · Journal of Hematology & Oncology · doi:10.1186/s13045-019-0833-3 · Cited by 510
Metadata
- Authors
- Ma, H., Liu, J., Ali, M. M., Mahmood, M. A. I., Labanieh, L., Lu, M., Iqbal, S. M., Zhang, Q., Zhao, W., & Wan, Y.
- Venue
- Chemical Society Reviews
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2015
- Volume
- 44
- Issue
- 5
- Pages
- 1240-1256
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W2163132518
- Cited by
- 265
- References
- 244
- FWCI
- 1.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.